The Patent Finder

Sustained-Release Formulations of Topiramate

Supernus Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 60/859,502, filed Nov 17, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,877,248Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 8,992,989Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,549,940Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,555,004Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 9,622,983Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 10,314,790Sustained-Release Formulations of Topiramate
In force
 · Medium confidence
Supernus Pharmaceuticals, Inc.In force
Medium confidence
US 8,298,576Sustained-Release Formulations of Topiramate
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited